Innovating Works
VSV-EBOVAC: Vaccine safety and immunogenicity signatures of human responses to VSV ZEBOV Sofia ref. 115842 BIOPROTECTION SYSTEMS CORPORATION participó en un H2020: H2020-JTI-IMI2-2014-02-single-stage The proposal, VSV-EBOVAC, directly addresses the topic 1 of the IMI2 call on Ebola by supporting the clinical development of a highly promis...
2015-03-19 - 2019-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.